Get a free sample of Cytomegalovirus (CMV) Treatment Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Cytomegalovirus (CMV) Treatment Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cytomegalovirus Treatment Market Size
Cytomegalovirus Treatment Market size was valued at USD 474.6 million in 2023 and is anticipated to register a CAGR of 6.6% between 2024 and 2032. This growth is propelled by increasing awareness and prevalence of CMV infection, as well as the development of new and effective treatments. For instance, according to the National Library of Medicine report of August 2023, CMV infects approximately 60% to 70% of adults in developed countries and nearly 100% in developing economies, driving demand for CMV treatment.
Cytomegalovirus (CMV) treatment involves the use of antiviral drugs to manage CMV infections. CMV is a common virus known to cause serious complications, particularly in individuals with weakened immune systems such as those with HIV/AIDS, organ transplant recipients, and newborns. The primary goals of treatment are to alleviate symptoms, halt disease progression, and improve patient outcomes.
How big is the North America CMV treatment industry?
North America CMV treatment market is set to exhibit robust growth between 2024 and 2032 owing to the increasing consumer awareness, growing incidences of cytomegalovirus infections, and the presence of key market players in the region.
Why is the demand for ganciclovir-based cytomegalovirus treatment increasing?
The ganciclovir drug type generated USD 162.5 million in revenue in 2023 and is estimated to record high demand by 2032 driven by the increasing number of solid organ and hematopoietic stem cell transplants globally.
What is the size of the cytomegalovirus treatment market?
Cytomegalovirus (CMV) treatment industry size reached USD 474.6 million in 2023 and is poised to expand at 6.6% CAGR from 2024-2032 propelled by increasing awareness and prevalence of CMV infection, as well as the development of new and effective treatments.
Who are the leading players operating in the cytomegalovirus treatment industry?
Some of the major companies engaged in the CMV treatment industry are Chimerix, Clinigen Group PLC, F. Hoffmann-La Roche Ltd, Genentech Inc., Gilead Sciences, Inc., Merck & Co. Inc, Mylan N.V, Pfizer, Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals Inc, and Thermo Fisher Scientific Inc.